Clinical Trial Update: A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) [Phase 3]

View source ↗

Summary

A phase 3 randomized trial investigated strategies to prevent congenital cytomegalovirus infection, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection
• Maternal Cytomegalovirus Infection

Snippet

Sponsor: The George Washington University Biostatistics Center | Conditions: Congenital Cytomegalovirus Infection, Maternal Cytomegalovirus Infection | Phase 3 | Status: COMPLETED | Results posted: 2023-02-02